Taiwan-based Genic Biotech (科苗生物科技公司) announced yesterday that the company has successfully completed a series of drug tests on animals for its new product "Genic." The result shows that "Genic" can effectively inhibit Human Immunodeficiency Virus (HIV) within four days of its administration.
According to Genic Vice President Lin Chih-hui (林枝輝), the drug is made from five traditional Asian herbs and has been proven by a German experiment to be capable of repressing HIV activity by as much as 98 percent. The company is now applying for government approval to conduct clinical experiments to determine the effects of the drug on human subjects.
Lin said that his company is planning to work with the Taipei Veterans General Hospital (台北榮總) to select 60 local AIDS patients who will take the new drug for six months. Every four weeks, blood samples from the test subjects will be sent to the Aaron Diamond AIDS Research Center at Rockefeller University in New York, where renowned AIDS researcher and Time magazine's 1996 Man of the Year David Ho (何大一) will analyze the samples to determine the drug's effectiveness.
According to Ho, who developed the "cocktail" therapy to combat the AIDS virus, the new drug may become Taiwan's most successful bio-technology product ever.
RSS